about
In-hospital prognosis and long-term mortality of STEMI in a reperfusion network. "Head to head" analysis: invasive reperfusion vs optimal medical therapy.Secondary prevention strategies after an acute ST-segment elevation myocardial infarction in the AMI code era: beyond myocardial mechanical reperfusion.Long-term outcome of transitory "reversible" complete atrio-ventricular block unrelated to myocardial ischemia.Long-term prognosis of first myocardial infarction according to the electrocardiographic pattern (ST elevation myocardial infarction, non-ST elevation myocardial infarction and non-classified myocardial infarction) and revascularization procedures.Trends in in-hospital mortality and six-month outcomes in patients with a first acute myocardial infarction. Change over the last decade.Sex-based Differences in Clinical Features, Management, and 28-day and 7-year Prognosis of First Acute Myocardial Infarction. RESCATE II StudySpontaneous coronary artery dissection in ergotamine abuse.[Temporary pacemakers: current use and complications][Duration of complete atrioventricular block complicating inferior wall infarction treated with fibrinolysis]Reduction in door-to-needle time to meet clinical guideline recommendations. Outcomes after 1 yearIn-hospital acquired anemia in acute coronary syndrome. Predictors, in-hospital prognosis and one-year mortalityβ-Blocker treatment and prognosis in acute coronary syndrome associated with cocaine consumption: The RUTI-Cocaine StudyIron Deficiency Is a Determinant of Functional Capacity and Health-related Quality of Life 30 Days After an Acute Coronary SyndromePrimary Ventricular Fibrillation in the Primary Percutaneous Coronary Intervention ST-Segment Elevation Myocardial Infarction Era (from the "Codi IAM" Multicenter Registry)Comorbidity and low use of new antiplatelets in acute coronary syndromeGrowth differentiation factor 15 and early prognosis after out-of-hospital cardiac arrestTrends in prevalence and outcomes of acute coronary syndrome associated with cocaine consumption: The RUTI-cocaine studyGrowth differentiation factor-15 is a predictive biomarker in primary ventricular fibrillation: The RUTI-STEMI-PVF studyMolecular signature of cardiogenic shockAcute-phase dynamics and prognostic value of growth differentiation factor-15 in ST-elevation myocardial infarctionChange in neuron specific enolase levels in out-of-hospital cardiopulmonary arrest survivors as a simple and useful tool to predict neurological prognosisProtein-based cardiogenic shock patient classifierCirculating MiRNA Dynamics in ST-Segment Elevation Myocardial Infarction-driven Cardiogenic Shock
P50
Q33733779-87F92E22-6D8B-4EF4-9503-11E4221701D0Q36273208-85ACB7AE-C284-4CC9-9946-29FD7D1F270CQ51116305-50E003A6-6362-485B-BF00-27878D52899EQ51434636-DCD109B9-4568-42F0-9519-A1842F88B5EDQ51750546-80475026-48D3-4626-8873-1AAA752A81A6Q57235769-DB839E16-370D-44A4-9431-887E7DB63410Q64963432-E4D74C62-CA07-4707-8C09-03316E47B3D2Q81009648-48621DFD-BF73-44B8-BCEA-C608FBACB647Q81338752-7E93290A-F9AC-42F1-B0E6-3AC490A737D2Q81750694-9D71E17E-43AC-40D8-AD74-2D7F0BAF4008Q84400424-BA5370A7-4C9B-41E6-8337-98933529CA5DQ88286092-D8EC72BC-BD6F-47BE-9E6F-0D5828FACA82Q88747822-495C00C0-DE5C-4AE3-8F54-83EF121EFEF5Q89364292-F943505E-1BCA-4B04-AD03-0A5EA551B163Q90203258-B90B1509-B947-42E4-88E9-7DDCAA43F4BFQ90785603-520E08E6-8661-4820-A1AD-A86C7CF31158Q90813287-7FC74221-CD21-4731-A4CE-D2CABFA695A7Q91269596-F3BD991E-E360-4FF5-B959-3F46A68F259AQ91269690-29F8041D-3D0B-4884-9A22-0996C2A55039Q91304835-60AA616A-68FE-4E27-B47B-94E74F8C7B6EQ92763653-C53E66E5-EF14-4E3D-AD15-C88992C2D40FQ92783569-CEDF31D8-B6B9-44DD-B631-9CECDA2D5BC9Q93343039-811AB8D4-0632-497A-B667-084757D5E9C6
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Cosme Garcia Garcia
@en
Cosme Garcia Garcia
@nl
type
label
Cosme Garcia Garcia
@en
Cosme Garcia Garcia
@nl
prefLabel
Cosme Garcia Garcia
@en
Cosme Garcia Garcia
@nl
P31
P496
0000-0001-6330-1677